Bowen Therapy for Chronic Non-specific Low Back Pain
Launched by THE HONG KONG POLYTECHNIC UNIVERSITY · Apr 22, 2021
Trial Information
Current as of May 14, 2025
Unknown status
Keywords
ClinConnect Summary
Low back pain (LBP) is one of the most common condition resulting in socioeconomic burden on health care systems. LBP is defined as pain, muscle tension, or stiffness in the area between the lower posterior margin of the rib cage and the horizontal gluteal fold with or without leg pain. Acute LBP is defined as pain that lasts less than 6 weeks, sub-acute LBP lasts for 6 to 12 weeks, and chronic LBP lasts for longer than 12 weeks. Prevalence study in Hong Kong showed that an estimated 57.1% and 42.1% of the population reported of LBP at least once in their life time and at least once within ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • ages between 18 and 65 years
- • a diagnosis of low back pain with onset \> 12 weeks based on the evaluation by physician
- • average pain intensity score of ≥ 3 on NPRS.
- Exclusion Criteria:
- • they have acute disc prolapse or protusion with neurological sign and symptoms in the past 3-months;
- • bacterial spondylitis;
- • Rheumatoid arthritis;
- • ankylosing spondylitis;
- • back pain secondary to bone malignancy
- • spinal fracture;
- • osteoporotic collapse;
- • cauda equina compression
- • prior spinal surgery;
- • psychiatric disorder (e.g. psychosis / delusion);
- • current pregnancy
- • previous experience with Bowen therapy.
About The Hong Kong Polytechnic University
The Hong Kong Polytechnic University (PolyU) is a leading institution in applied research and education, dedicated to advancing knowledge and innovation in various fields, including health sciences. As a clinical trial sponsor, PolyU focuses on conducting rigorous and ethically sound research to enhance understanding of medical interventions and improve patient outcomes. The university leverages its multidisciplinary expertise, state-of-the-art facilities, and collaboration with industry partners to facilitate groundbreaking studies that address pressing health challenges. Committed to fostering an environment of academic excellence, PolyU aims to translate research findings into practical solutions that benefit society and contribute to the global advancement of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kwun Tong, , Hong Kong
Patients applied
Trial Officials
Andy S.K. Cheng, PhD
Principal Investigator
The Hong Kong Polytechnic University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials